The Management’s General Assessment of Business Performance
2010 was an exceptionally successful year for our Company: Revenue and earnings climbed to record levels. We achieved, and in some cases even exceeded, all the targets we set ourselves at the beginning of the year.
Fresenius Medical Care experienced stronger growth than the dialysis industry as a whole. As a result, we managed to increase our share of the global market. We also clearly maintained our position as market leader in North America, by far our biggest market, and recorded significant revenue growth in some of the markets outside of North America (Europe, Latin America and Asia), reinforcing our market position in these regions.
In addition, Fresenius Medical Care continued to boost its profitability in the year under review. Once again, there were improvements in all relevant key figures. This is partly due to our ongoing high level of investments in maintaining existing clinics, equipping new facilities, and expanding production capacities.